The Genomic Medicine Revolution: Multi-Modality Approaches in Advanced Therapies
Pharmaceutical Technology
AUGUST 16, 2024
Genomic medicines offer new techniques for treating conditions once thought to be intractable - a world of opportunity awaits.
Genomics Related Topics 
Tome Biosciences debuts with $213M and a new way to edit the genome
Bio Pharma Dive
DECEMBER 12, 2023
Based on the work of MIT scientists, the well-funded startup is developing ways to insert large sizes of genetic material anywhere in the genome without damaging or breaking DNA.
Genome 
330
330 Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
EU pharma trade body starts genomic profiling initiative to improve access
Pharmaceutical Technology
JUNE 20, 2023
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and selected pharma and medical device companies have launched the European Coalition for Access to Comprehensive Genomic Profiling (ECGP), to promote the routine use of comprehensive genomic profiling.
Genomics 264
264 
AstraZeneca, seeking new drug targets, taps a genomics biotech and its AI technology
Bio Pharma Dive
SEPTEMBER 8, 2023
Worth up to $840 million, the collaboration will give Alexion access to Verge Genomics’ platform, which uses human tissue data to find drug targets for diseases that degrade the nerve system.
Genome 290
290 
NHS Wales partners with Illumina on genomics drive
pharmaphorum
NOVEMBER 8, 2024
Wales has extended a scheme to harness the power of genomics to improve cancer care and prevention via an alliance with gene-sequencing giant Illumina.
Genome 103
103 
Tome acquires startup Replace, gaining new genome editing tools
Bio Pharma Dive
JANUARY 2, 2024
The deal is the second startup sale engineered by University of California, Berkeley scientist Shakked Halperin, and gives Tome a way to insert or delete small DNA sequences into the genome.
Genome 173
173 
GUARDIAN Study Reveals How Genomic Sequencing Could Bridge Gaps in Newborn Screening
XTalks
OCTOBER 29, 2024
Genomic sequencing is a window into our genetic makeup. The GUARDIAN (Genomic Uniform-screening Against Rare Diseases In All Newborns) study, recently published in the Journal of the American Medical Association (JAMA) , highlights how adding genome sequencing to newborn screening could reshape early detection for rare genetic conditions.
Genomics 79
79 
The new genomic frontier: Next-generation data management takes flight
pharmaphorum
JUNE 21, 2024
Explore the latest advancements in genomics and sequencing technologies, and learn how next-generation data management tools are transforming genomic research and applications in this new genomic frontier.
Genomics 105
105 
Analyze whole genome sequencing samples at the speed of light
Bio Pharma Dive
FEBRUARY 13, 2023
Deliver fast and reliable results at low cost with a tool for whole genome analysis in just minutes
Genome 246
246 
Data-driven disease research harnessing the genome
pharmaphorum
JANUARY 9, 2024
Discover how the UK Biobank is leveraging technology and the power of genomics in data-driven disease research. Join the digital revolution in understanding and combating diseases using cutting-edge techniques and large-scale genomic data analysis.
Genome 122
122 
Hopewell Therapeutics raises funds for genomic medicines development
Pharmaceutical Technology
JUNE 8, 2023
Biotechnology company Hopewell Therapeutics has raised $25m in seed financing to accelerate the development of next-generation lipid nanoparticles for targeted delivery of genomic medicines. Hopewell Therapeutics is engaged in discovering, synthesising and developing advanced ttLNPs to provide next-generation genomic medicines.
Genome 130
130 
How Will Ultima Genomics and Genome Insight Make WGS Affordable?
XTalks
APRIL 21, 2023
The application of whole genome sequencing (WGS) to derive a more complete understanding of cancer has been a central goal of cancer researchers even before the first human genome was decoded in 2003. Ultima Genomics has already partnered with other leading biotech startups.
Genome 92
92 
Working for a mature form of genomic medicines
pharmaphorum
MAY 29, 2024
In a new episode of the pharmaphorum podcast, Rahul Kakkar, CEO of gene editing company Tome, speaks with web editor Nicole Raleigh about programmable genomic integration (PGI) technology.
Genome 116
116 
Short reads, big impact: How genomics is revolutionising cancer research
pharmaphorum
MAY 30, 2024
Discover how genomics is transforming cancer research through the study of DNA, RNA, and ctDNA. Learn about the latest breakthroughs in the field in this insightful short read.
Genome 126
126 
From promise to reality: Unlocking the true business potential of genomic medicine
pharmaphorum
NOVEMBER 21, 2024
Explore how investing in genomic medicine can unlock the true business potential in the manufacturing and therapeutic areas. Understand the promise and reality of this cutting-edge field.
Genome 52
52 
UK study backs whole-genome screening for cancer care
pharmaphorum
JANUARY 10, 2024
UK study led by Genomics England drawing on 100,000 Genomes Project and real-world clinical data backs use of whole-genome sequencing in cancer care
Genomics 102
102 
Royal Marsden launches first UK genome testing facility to improve testing for cancer
Pharma Times
JUNE 14, 2024
The installation will double the capacity of cancer genomic testing using robotic automation
Genome 117
117 
Access to genomic surveillance: Open science and public health
pharmaphorum
OCTOBER 16, 2024
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens. The technology proved vital in aiding understanding of the evolution of and spread of virus in real time to inform public health measures, ultimately accelerating drug and vaccine development.
Genome 69
69 
A new dawn of the genomic age: five areas set to be transformed in 2023
pharmaphorum
JANUARY 26, 2023
2022 was a banner year for genomics. In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 billion base pairs that make up our DNA.
Genome 128
128 
Investment fuels AI-driven development of breakthrough genomic medicines
pharmaphorum
OCTOBER 12, 2022
David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says.
Genomics 103
103 
Genome Research publishes a special issue in Single-cell Genomics
Scienmag
OCTOBER 1, 2021
October 1, 2021 – Genome Research ([link] publishes a special issue highlighting novel advances and insights in Single-cell Genomics. October 1, 2021 – Genome Research ([link] publishes a special issue highlighting novel advances and insights in Single-cell Genomics. Credit: Cover artwork © Victor O.
Genome 88
88 
Mission Bio launches genome editing solution for Advanced Therapies
BioPharma Reporter
SEPTEMBER 12, 2023
Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, has launched its new Tapestri Genome Editing Solution.
Genome 124
124 
Genomic projects exploit scale as clinical applications play catch-up
Pharmaceutical Technology
JUNE 30, 2022
Analysing almost eight thousand tumours across 33 different cancers, researchers say this marks the first time that a framework was created to understand the role of internal factors in driving such genomic alterations. Genomic research have greatly expanded our understanding of disease pathophysiology over the years.
Genome Project 130
130 
Genome Edited Foods: Understanding the New FDA Guidance
XTalks
MARCH 1, 2024
In a pivotal move for the food industry, the US Food and Drug Administration (FDA) has unveiled industry guidance for genome edited foods derived from plants. This landmark guidance aims to demystify the FDA’s risk-based approach towards both genome edited foods and all new plant varieties. What is Genome Editing?
Genome 69
69 
Magazine: Genomic projects exploit scale as clinical applications play catch-up
Pharmaceutical Technology
JULY 26, 2022
The last few months have marked the publication of research emerging from projects designed to collect and analyse genomic data on a wider scale than was previously thought possible. The post Magazine: Genomic projects exploit scale as clinical applications play catch-up appeared first on Pharmaceutical Technology.
Genome Project 130
130 
Experts prefer whole genome sequencing as viable option to identify & characterize bacteria as concerns of AMR escalate
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 18, 2023
As antimicrobial resistance (AMR) poses a growing threat to global public health, challenging the effectiveness of antibiotics and other antimicrobial drugs, medical experts suggest whole genome sequencing as a viable option to identify and characterize the bacteria, viruses, fungi or parasites, along with their transmission pattern.
Bacteria 131
131 
UK Biobank releases largest-ever genome sequencing dataset
pharmaphorum
NOVEMBER 30, 2023
UK Biobank releases largest-ever genome sequencing dataset Phil.Taylor Thu, 30/11/2023 - 10:00 Bookmark this
Biobanking 110
110 
Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research
Pharma Mirror
NOVEMBER 16, 2021
Rockville, Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced a partnership with MedGenome aimed at accelerating breakthrough treatments, powered by human genomics, for rare disease patients.
Genomics 130
130 
Modernizing cell culture processes for the next wave of genomic medicine
Pharmaceutical Technology
FEBRUARY 3, 2023
The field of genomic medicine has reached a true turning point. More efficient, suspension-based cell culture processes are urgently needed in the now fast-developing genomic medicine space. © 2022 Cytiva The post Modernizing cell culture processes for the next wave of genomic medicine appeared first on Pharmaceutical Technology.
Genome 244
244 
STAT+: ??Genomics is racing toward a $100 genome. Are we ready for it?
STAT News
JULY 27, 2022
As the cost of DNA sequencing plummets, we’re fast approaching a point when decoding a human genome could cost $100 — about as much as the average American’s weekly grocery store run. Health systems are preparing to test programs that could lead to the use of whole-genome screening in millions of newborns.
Genomics 105
105 
Kansas children’s hospital first to use world’s most advanced genomic sequencing
BioPharma Reporter
OCTOBER 10, 2023
Childrenâs Mercy Kansas City, an independent pediatric health organization, has become the first health care system to replace old genetic tests, such as rapid exome and chromosomal microarray analysis, with the worldâs most-advanced genomic sequencing technology from PacBio.
Genome 101
101 
How Hazel Jones is charting new horizons in genomics
BioPharma Reporter
MAY 15, 2024
Hazel Jones is the interim CEO and chief operations officer at Enhanc3D Genomics. We sat down with her to discuss her leap of faith into 3D genomics, and how she is scaling the business and driving operational change.
Genome 52
52 
Oxford Nanopore and UK to develop pathogen surveillance system
Pharmaceutical Technology
NOVEMBER 5, 2024
This initiative brings together UK Biobank, Genomics England, NHS England, and Oxford Nanopore to accelerate genomics-based research in the UK.
Biobanking 147
147 
Genomic testing ‘should be offered to all cancer patients in Scotland’
pharmaphorum
NOVEMBER 27, 2022
A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs. The post Genomic testing ‘should be offered to all cancer patients in Scotland’ appeared first on. Why not lead?”
Genome 99
99 
The future, now: Revolutionising disease prevention through predictive genomics
pharmaphorum
JUNE 30, 2023
The future, now: Revolutionising disease prevention through predictive genomics Mike.Hammerton Fri, 30/06/2023 - 08:00 Bookmark this
Genome 97
97 
Congenica extends contract with Hong Kong Genome Project
BioPharma Reporter
OCTOBER 9, 2023
Congenica, a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale, has announced a two-year extension to its contract for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in Hong Kong.
The future of genomic medicine: can it fulfil its promises?
pharmaphorum
SEPTEMBER 14, 2020
Here he gives us a deeper look at how genomic medicine is evolving and the barriers that are preventing it from reaching its full potential. I saw this, in particular, with the finishing of the human genome,” says Charlie. “At In reality, finishing the human genome was the first step of what is a long journey.”.
Genome 118
118 
Large European study underlines power of genomic sequencing to diagnose diseases
STAT News
APRIL 12, 2023
LONDON — Using genome sequencing greatly expanded the number of diagnoses researchers could provide for children with developmental disorders from thousands of families across the United Kingdom and Ireland, researchers reported in a new study Wednesday. Read the rest…
Genome 98
98 
USDA-ARS releases genome of the voracious desert locust
Scienmag
JUNE 26, 2022
June 27, 2022–The first high-quality genome of the desert locust—those voracious feeders of plague and devastation infamy and the most destructive migratory insect in the world—has been produced by U.S. June 27, 2022–The first high-quality genome of the desert locust—those voracious feeders of […].
Genome 89
89 
Oncotype DX: Breast cancer, genomics, and rethinking the oncology paradigm
pharmaphorum
JULY 27, 2023
Oncotype DX: Breast cancer, genomics, and rethinking the oncology paradigm Mike.Hammerton Thu, 27/07/2023 - 08:00 Bookmark this
Genome 96
96 
As the Smithsonian wraps a landmark genome exhibit, leaders in the field reflect on what’s changed
STAT News
AUGUST 17, 2022
When the Smithsonian National Museum of Natural History opened its genomics exhibit in 2013, the field was just celebrating the 10th anniversary of the completed Human Genome Project. Sequencing that first genome cost over $500 million. The genomes since cost $10,000. The development of CRISPR-Cas9 landed a Nobel Prize.
Genome 98
98 
The use of genomic profiling testing to improve oncology care
pharmaphorum
SEPTEMBER 12, 2022
Alongside drugs and therapeutics, data collection and technology enhancements have redefined the traditional healthcare experience, especially within oncology, and genomic profiling has become a significant factor in allowing for personalised care. The post The use of genomic profiling testing to improve oncology care appeared first on.
Genome 105
105 
UK announces mass genome sequencing programme for newborns
Medical Xpress
DECEMBER 13, 2022
UK health authorities on Tuesday announced a pioneering research programme using the genomes of 100,000 new-born babies, to detect rare genetic illnesses and speed up treatment.
Genome 97
97 
Gaps in breast cancer care in Europe and the importance of genomic testing
pharmaphorum
JUNE 23, 2023
Gaps in breast cancer care in Europe and the importance of genomic testing Mike.Hammerton Fri, 23/06/2023 - 08:00 Bookmark this
Genome 112
112 
Let's personalize your content